ReviewEuropean archives of psychiatry and clinical neuroscience2023

Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophrenia.

Holger Rosenbrock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.